Yaojin Peng

Dr. Yaojin Peng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2023 in Science China Life Sciences
Verified
Journal Article
Closed access
HBHainan Bao
Hainan Bao
JCJiani Cao
Jiani Cao
MCMengting Chen
Mengting Chen
MCMin Chen
Min Chen
WCWei Chen
Wei Chen
GLGuang-Hui Liu
Guang-Hui Liu

22 December 2021 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
XCXiaoyong Chen
Xiaoyong Chen
JHJing Huang
Jing Huang
JWJun Wu
Jun Wu
JHJie Hao
Jie Hao
BFBoqiang Fu
Boqiang Fu
AXAndy Peng Xiang
Andy Peng Xiang
Mesenchymal stem cells (MSCs) have attracted great interest for cell therapy and tissue regeneration due to their self‐renewal capacity, multipotency and potent immunomodulatory effects on immune cells. However, heterogeneity of MSCs has become a prominent obstacle to limit their translation into practice, as cells from different tissue sources or each individual have great differences in their transcriptomic signatures, differentiation potential and biological functions. Therefore, there is an urgent need for consensus standard for the quality control and technical specifications of MSCs. ‘Human Mesenchymal Stem Cells’ is the latest set of guidelines on hMSC in China, jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research. This standard specifies the technical requirements, test methods, test regulations, instructions for use, labelling requirements, packaging requirements, storage requirements, transportation requirements and waste disposal requirements for hMSC, which is applicable to the quality control for hMSC. It was originally released by the China Society for Cell Biology on 9 January 2021. We hope that publication of these guidelines will facilitate institutional establishment, acceptance and execution of proper protocols, and accelerate the international standardization of hMSC for clinical development and therapeutic applications.

1 November 2021 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
JCJiani Cao
Jiani Cao
JHJie Hao
Jie Hao
LWLei Wang
Lei Wang
YTYuanqing Tan
Yuanqing Tan
YTYuchang Tian
Yuchang Tian
TZTongbiao Zhao
Tongbiao Zhao
Stem cells, which could be developed as starting or raw materials for cell therapy, hold tremendous promise for regenerative medicine. However, despite multiple fundamental and clinical studies, clinical translation of stem cells remains in the early stages. In contrast to traditional chemical drugs, cellular products are complex, and efficacy can be altered by culture conditions, suboptimal cell culture techniques, and prolonged passage such that translation of stem cells from bench to bedside involves not only scientific exploration but also normative issues. Establishing an integrated system of standards to support stem cell applications has great significance in efficient clinical translation. In recent years, regulators and the scientific community have recognized gaps in standardization and have begun to develop standards to support stem cell research and clinical translation. Here, we discuss the development of these standards, which support the translation of stem cell products into clinical therapy, and explore ongoing work to define current stem cell guidelines and standards. We also introduce general aspects of stem cell therapy and current international consensus on human pluripotent stem cells, discuss standardization of clinical-grade stem cells, and propose a framework for establishing stem cell standards. Finally, we review ongoing development of international and Chinese standards supporting stem cell therapy.

1 October 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
YPYaojin Peng
Yaojin Peng
XHXiaoru Huang
Xiaoru Huang
QZQi Zhou
Qi Zhou

17 May 2022 in Cell Proliferation
Verified
Journal Article
Open access
LDLulu Ding
Lulu Ding
ZXZhenyu Xiao
Zhenyu Xiao
XGXia Gong
Xia Gong
YPYaojin Peng
Yaojin Peng
Objectives: The rapid development of cerebral organoid technology and the gradual maturity of cerebral organoids highlight the necessity of foresighted research on relevant ethical concerns. We employed knowledge graphs and conducted statistical analysis with CiteSpace for a comprehensive analysis of the status quo of the research on the ethical concerns of cerebral organoids from a bibliometric perspective.Materials and Methods: We performed a statistical analysis of published papers on cerebral organoid ethics, keyword co‐occurrence graph, literature co‐citation and knowledge clustering graph to examine the status of the ethics research, internal relationship between technological development and ethical research, and ethical concerns of the academia. Finally, we used a keyword time zone graph and related statistics to analyze and predict the trends and popular topics of future cerebral organoids ethics research.Results: We demonstrated that although the ethical concerns of cerebral organoids have long been discussed, it was not until 2017 that the ethical issues began to receive more attention, when cerebral organoids were gradually mimicking the human brain more closely and increasingly being combined with chimera research. The recent key ethical concerns are primarily divided into three categories: concerns that are common in life sciences, specific to cerebral organoids, and present in cross‐fields. These increasing ethical concerns are inherently related to the continual development of technology. The analysis pointed out that future research should focus on the ethical concerns of consciousness that are unique to cerebral organoids, ethical concerns of cross‐fields, and construction and improvement of legislative and regulatory systems.Conclusions: Although research on cerebral organoids can benefit the biomedicine field, the relevant ethical concerns are significant and have received increasing attention, which are inherently related to the continual development of technology. Future studies in ethics regarding cerebral organoid research should focus on the ethical concerns of consciousness, and cross‐fields, as well as the improvement of regulatory systems.

26 April 2023 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
YPYaojin Peng
Yaojin Peng
LDLulu Ding
Lulu Ding
MSMoshi Song
Moshi Song
ZXZhenyu Xiao
Zhenyu Xiao
JLJianwei Lv
Jianwei Lv
GLGuang-Hui Liu
Guang-Hui Liu